Live feed
Filing
SC 13G
SC 13G0001137774-18-000008·Eiger BioPharmaceuticals, Inc.
Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 604,293
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-18-000008
- Form type
- SC 13G
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Jan 19, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership